catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025) Certified by Founder
Lodge
Scorpion Therapeutics
start up
- 17/07/2024
- Series C
- $150,000,000
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology. For more information, visit scorpiontx.com.
- Industry Biotechnology Research
- Website https://www.scorpiontx.com/
- LinkedIn https://www.linkedin.com/company/scorpiontherapeutics/
Ornn | $5,700,000 | (Nov 4, 2025)
Helex | $3,500,000 | (Nov 4, 2025)
Mem0 | $24,000,000 | (Oct 30, 2025)
Mondra | $13,206,500 | (Oct 30, 2025)
hoop.dev | Undisclosed Amount | (Oct 30, 2025)
FrontlineIQ | $3,300,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Recess | $30,000,000 | (Oct 30, 2025)